Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BUSCOPAN INJECTION FOR HORSES DIN 02282089

Status: Marketed
Holder: BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
Molecule: HYOSCINE BUTYLBROMIDE

Health Canada record

Active ingredient(s)HYOSCINE BUTYLBROMIDE 20 MG
Dosage formSolution
RouteIntravenous
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date03-Mar-2008
Current status date12-Aug-2020
SourceHealth Canada DPD

Establishment licence of the holder

Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing HYOSCINE BUTYLBROMIDE

DINProductCompanyFormStrengthStatus
02512335ACCEL-HYOSCINEACCEL PHARMA INCTabletHYOSCINE BUTYLBROMIDE 10 MGMarketed
00363812BUSCOPANSANOFI CONSUMER HEALTH INCTabletHYOSCINE BUTYLBROMIDE 10 MGMarketed
00363839BUSCOPANSANOFI CONSUMER HEALTH INCSolutionHYOSCINE BUTYLBROMIDE 20 MGMarketed
02229868HYOSCINE BUTYLBROMIDE INJECTIONSANDOZ CANADA INCORPORATEDSolutionHYOSCINE BUTYLBROMIDE 20 MGMarketed
02560984HYOSCINE BUTYLBROMIDE INJECTIONAS KALCEKSSolutionHYOSCINE BUTYLBROMIDE 20 MGApproved
02508419HYOSCINE BUTYLBROMIDE INJECTION BPOMEGA LABORATORIES LIMITEDSolutionHYOSCINE BUTYLBROMIDE 20 MGMarketed
00363820BUSCOPAN SUP 10MGBOEHRINGER INGELHEIM (CANADA) LTD LTEESuppositoryHYOSCINE BUTYLBROMIDE 10 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
240172020-08-12New Drug Submission (NDS)Administrative: Change in Product Ownership
81292006-07-10New Drug Submission (NDS)

International API supply for HYOSCINE BUTYLBROMIDE

7 valid EDQM Certificates of Suitability from 7 holders.

Request a quote for BUSCOPAN INJECTION FOR HORSES

How to read a Canadian DIN record